NEUP — Neuphoria Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Neuphoria Therapeutics, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	R2023 June 30th	2024 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	fx Final	fx Final	fx Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3.16	21.7	23.2	12.1	12.6
Net Total Accounts Receivable
Net Total Receivables	2.06	0.848	4.68	0.426	0.127
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5.75	23.2	28.9	13.3	13.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.728	0.653	0.465	0.333	0.219
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	23.8	40.7	45.1	28.6	27.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.71	1.77	2.32	2.74	3.83
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	15	5	5.79	6.55	10.2
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.75	35.7	39.3	22	17.5
Total Liabilities & Shareholders' Equity	23.8	40.7	45.1	28.6	27.6
Total Common Shares Outstanding